Biography
I am graduated from the School of Medicine, Zhejiang University, MD. A visiting scholar at the Bloomberg School of Public Health, Johns Hopkins University, USA. I have been engaged in tuberculosis clinical work for 17 years . My interest major in clinical and basic research on drug-resistant tuberculosis and nontuberculous mycobacteria.
Key Impacts
The value of SAT-TB in monitoring the early therapeutic efficacy of MDR/RR tuberculosis
At the end of the first month of treatment,sputum SAT-TB showed high consistency with MGIT™960 culture in evaluating therapeutic efficacy,indicating that sputum SAT-TB has certain application value in the early therapeutic efficacy evaluation of MDR/RR-TB.
Source: Conference 2024